NASDAQ · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE · MID CAP
The Oncology Institute, Inc. TOI
6 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$502.7M
▲ 27.8% vs FY2024
EPS · FY25
—
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
—
Net margin · FY25
-12.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 502.7M
Revenue, FY2025 · full 6-year series below
Revenue
Net income
The company lost 12 cents on every revenue dollar this year.
Per share
—
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
—
Return on equity, FY2025
ROE
Operating margin-7.2%
Net margin-12.1%
Return on assets-35.9%
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+21.8% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+25.8%
+21.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 164.7M
total assets, end of FY2025
Total assetsUSD 164.7M
EquityUSD -15.7M
CashUSD 33.6M
Gross debtUSD 77.4M
Net debtUSD 43.8M
Current ratio1.59×
Net debt stands at -279% of equity.
History
6 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
Revenue $B
0.5
0.4
0.3
0.3
0.2
0.2
Operating income $B
−0.0
−0.1
−0.1
−0.1
−0.0
−0.0
EBITDA $B
−0.0
−0.1
−0.1
−0.1
−0.0
−0.0
Income tax $B
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
Net income $B
−0.1
−0.1
−0.1
0.0
−0.0
−0.0
EPS, diluted $
·
·
·
·
·
·
Dividend / sh $
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
ROE %
·
−213.4
−92.2
0.1
−16.5
−40.7
Shares out B
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
19 of 20
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 1 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed